Cargando…

Thermoresistant Newcastle disease vaccine effectively protects SPF, native, and commercial chickens in challenge with virulent virus

BACKGROUND: Due to the more stability and a better homogenecity in immune response, the use of thermoresistant vaccines in different chicken types has been increased. OBJECTIVE: This study aimed to evaluate the efficacy of a newly developed Newcastle disease vaccine (ND.TR.IR) originating from I‐2 s...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdoshah, Mohammad, Hassanzadeh, Mohammad, Masoudi, Shahin, Ashtari, Abbas, Yousefi, Ali Reza, Partovi Nasr, Minoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297754/
https://www.ncbi.nlm.nih.gov/pubmed/35353959
http://dx.doi.org/10.1002/vms3.794
_version_ 1784750541344079872
author Abdoshah, Mohammad
Hassanzadeh, Mohammad
Masoudi, Shahin
Ashtari, Abbas
Yousefi, Ali Reza
Partovi Nasr, Minoo
author_facet Abdoshah, Mohammad
Hassanzadeh, Mohammad
Masoudi, Shahin
Ashtari, Abbas
Yousefi, Ali Reza
Partovi Nasr, Minoo
author_sort Abdoshah, Mohammad
collection PubMed
description BACKGROUND: Due to the more stability and a better homogenecity in immune response, the use of thermoresistant vaccines in different chicken types has been increased. OBJECTIVE: This study aimed to evaluate the efficacy of a newly developed Newcastle disease vaccine (ND.TR.IR) originating from I‐2 strain in specific pathogen‐free (SPF) and native and broiler chickens. METHODS: Following determination of pathogenicity indices on the candidate seed, three efficacy examinations were conducted. In the first experiment, 120 1‐day‐old SPF chickens were randomly allocated to six groups and either vaccinated with ND.TR.IR via eye drop at 1, 7, and 21 days of age (V(1), V(7), and V(21)), or considered as non‐vaccinated control groups (C(1), C(7), and C(21)). At 20th post‐vaccination day, sera hemagglutination inhibition (HI) antibody titres against ND virus (NDV) were measured and then the chickens were challenged by virulent NDV (vNDV). In the second and third experiments, the efficacy of ND.TR.IR vaccine was compared to routine vaccination program (B1 and LaSota) in native and broiler chickens that were vaccinated at 10 and 20 days of age, respectively. The HI antibody titres were measured on 10, 20, 30, and 40 days of age, and also challenge efficacy test with vNDV was conducted on 30 days of age. RESULTS: The studied virus, as a vaccinal seed, complied with the pathogenicity indices of avirulent NDV and molecular identity of I‐2 strain. In the efficacy evaluation trials, the vaccinated chickens had higher HI antibody titres against NDV compared with their corresponding control chickens (p < 0.05). Results of the challenge tests indicated 95% and 100% protection against vNDV in native, SPF, and broiler‐vaccinated chickens, respectively. CONCLUSIONS: The present findings indicated that administration of ND.TR.IR induced appropriate HI antibody titres against NDV in SPF, native, and broiler chickens associated with good protection in efficacy test.
format Online
Article
Text
id pubmed-9297754
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92977542022-07-22 Thermoresistant Newcastle disease vaccine effectively protects SPF, native, and commercial chickens in challenge with virulent virus Abdoshah, Mohammad Hassanzadeh, Mohammad Masoudi, Shahin Ashtari, Abbas Yousefi, Ali Reza Partovi Nasr, Minoo Vet Med Sci POULTRY BACKGROUND: Due to the more stability and a better homogenecity in immune response, the use of thermoresistant vaccines in different chicken types has been increased. OBJECTIVE: This study aimed to evaluate the efficacy of a newly developed Newcastle disease vaccine (ND.TR.IR) originating from I‐2 strain in specific pathogen‐free (SPF) and native and broiler chickens. METHODS: Following determination of pathogenicity indices on the candidate seed, three efficacy examinations were conducted. In the first experiment, 120 1‐day‐old SPF chickens were randomly allocated to six groups and either vaccinated with ND.TR.IR via eye drop at 1, 7, and 21 days of age (V(1), V(7), and V(21)), or considered as non‐vaccinated control groups (C(1), C(7), and C(21)). At 20th post‐vaccination day, sera hemagglutination inhibition (HI) antibody titres against ND virus (NDV) were measured and then the chickens were challenged by virulent NDV (vNDV). In the second and third experiments, the efficacy of ND.TR.IR vaccine was compared to routine vaccination program (B1 and LaSota) in native and broiler chickens that were vaccinated at 10 and 20 days of age, respectively. The HI antibody titres were measured on 10, 20, 30, and 40 days of age, and also challenge efficacy test with vNDV was conducted on 30 days of age. RESULTS: The studied virus, as a vaccinal seed, complied with the pathogenicity indices of avirulent NDV and molecular identity of I‐2 strain. In the efficacy evaluation trials, the vaccinated chickens had higher HI antibody titres against NDV compared with their corresponding control chickens (p < 0.05). Results of the challenge tests indicated 95% and 100% protection against vNDV in native, SPF, and broiler‐vaccinated chickens, respectively. CONCLUSIONS: The present findings indicated that administration of ND.TR.IR induced appropriate HI antibody titres against NDV in SPF, native, and broiler chickens associated with good protection in efficacy test. John Wiley and Sons Inc. 2022-03-30 /pmc/articles/PMC9297754/ /pubmed/35353959 http://dx.doi.org/10.1002/vms3.794 Text en © 2022 The Authors. Veterinary Medicine and Science published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle POULTRY
Abdoshah, Mohammad
Hassanzadeh, Mohammad
Masoudi, Shahin
Ashtari, Abbas
Yousefi, Ali Reza
Partovi Nasr, Minoo
Thermoresistant Newcastle disease vaccine effectively protects SPF, native, and commercial chickens in challenge with virulent virus
title Thermoresistant Newcastle disease vaccine effectively protects SPF, native, and commercial chickens in challenge with virulent virus
title_full Thermoresistant Newcastle disease vaccine effectively protects SPF, native, and commercial chickens in challenge with virulent virus
title_fullStr Thermoresistant Newcastle disease vaccine effectively protects SPF, native, and commercial chickens in challenge with virulent virus
title_full_unstemmed Thermoresistant Newcastle disease vaccine effectively protects SPF, native, and commercial chickens in challenge with virulent virus
title_short Thermoresistant Newcastle disease vaccine effectively protects SPF, native, and commercial chickens in challenge with virulent virus
title_sort thermoresistant newcastle disease vaccine effectively protects spf, native, and commercial chickens in challenge with virulent virus
topic POULTRY
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297754/
https://www.ncbi.nlm.nih.gov/pubmed/35353959
http://dx.doi.org/10.1002/vms3.794
work_keys_str_mv AT abdoshahmohammad thermoresistantnewcastlediseasevaccineeffectivelyprotectsspfnativeandcommercialchickensinchallengewithvirulentvirus
AT hassanzadehmohammad thermoresistantnewcastlediseasevaccineeffectivelyprotectsspfnativeandcommercialchickensinchallengewithvirulentvirus
AT masoudishahin thermoresistantnewcastlediseasevaccineeffectivelyprotectsspfnativeandcommercialchickensinchallengewithvirulentvirus
AT ashtariabbas thermoresistantnewcastlediseasevaccineeffectivelyprotectsspfnativeandcommercialchickensinchallengewithvirulentvirus
AT yousefialireza thermoresistantnewcastlediseasevaccineeffectivelyprotectsspfnativeandcommercialchickensinchallengewithvirulentvirus
AT partovinasrminoo thermoresistantnewcastlediseasevaccineeffectivelyprotectsspfnativeandcommercialchickensinchallengewithvirulentvirus